Physicians' Academy for Cardiovascular Education

Consensus recommendations for ASCVD risk reduction in hypertriglyceridemia

News - Aug. 10, 2021

The ACC has published an Expert Consensus Decision Pathway (ECDP) on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia. The ECDP provides practical guidance in the form of clinical workflows on the management of hypertriglyceridemia in 4 patient populations:

The ECDP provides information about secondary causes of hypertriglyceridemia, lifestyle modifications in patients with hypertriglyceridemia (including detailed nutrition recommendations for patients with mild, moderate or severe hypertriglyceridemia), and use of statins and TG risk-based non-statin therapies for ASCVD risk reduction.

Find the 2021 ACC Expert Consensus Decision Pathway online at J Am Coll Cardiol.

Share this page with your colleagues and friends: